Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time
Rhea-AI Summary
Lantheus (NASDAQ: LNTH) will host a second quarter 2026 earnings conference call and webcast at 8:00 a.m. Eastern Time on Thursday, August 6, 2026. The event will cover financial results and a business update for the quarter. Participants must register online via the company’s investor relations events calendar. Lantheus encourages registration 15 minutes before the start time. A replay of the webcast will be available about two hours after the event and will remain archived on the same webpage for at least 30 days.
Positive
- None.
Negative
- None.
News Market Reaction – LNTH
In the Jul 23 session, LNTH declined 0.84%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 26 | FDA response | Negative | -0.2% | FDA issued a Complete Response Letter citing unresolved third-party manufacturing inspection conditions. |
| Jun 03 | Healthcare conference | Neutral | +4.1% | Lantheus announced executive participation in a Goldman Sachs healthcare conference fireside chat. |
| Jun 02 | Clinical recognition | Positive | -0.8% | LNTH-2513 received SNMMI’s 2026 Image of the Year award. |
| May 27 | Growth conference | Neutral | -1.0% | Lantheus announced executive participation in a William Blair growth stock conference fireside chat. |
| May 21 | Radiodiagnostic data | Positive | -1.7% | Lantheus announced presentations covering PSMA-PET and 18F-GP1 PET/CT data. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent conference, recognition, and radiodiagnostic-data announcements generally diverged from subsequent price direction, while the FDA response aligned with a negative reaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BEDFORD, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, August 6, 2026, to discuss its financial results and provide a business update for the second quarter of 2026.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visit www.lantheus.com.
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
Melissa Downs
Executive Director, External Communications
646-975-2533
media@lantheus.com